Oppenheimer recommends Express Scripts (ESRX) shares even if regulators shoot down the planned...

|About: Express Scripts, Inc. (ESRX)|By:, SA News Editor

Oppenheimer recommends Express Scripts (ESRX) shares even if regulators shoot down the planned acquisition of Medco (MHS). Already a valuation opportunity, if the buyout fails, Medco would be badly weakened after client losses and months of limbo. If the deal closes, ESRX would be left as the only major independent pharmacy benefits manager.